CMAC 2009; 11(3) | CMAC

CMAC 2009; 11(3)

Efficacy of antimicrobial treatment regimens in pregnant or non-pregnant women with bacterial vaginosis (BV) is difficult to evaluate. …
Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):196-210
PDF

The present article describes comparative pharmacokinetic study of different generic oral forms of amoxicillin — soluble tablets …
Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):211-217
PDF

Spiramycin, natural 16-membered macrolide antibiotic, was discovered in 1954. This antimicrobial agent is at least non-inferior to and …
Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):218-238
PDF

Piperacillin/tazobactam, penicillin/beta-lactamase inhibitor combination, has a broad antimicrobial spectrum, including most …
Клиническая Микробиология и Антимикробная Химиотерапия. 2009; 11(3):239-252
PDF

Influence of pharmacists on treatment selection in male patients with acute urethritis in 2003–2004 (Moscow, Smolensk, Kaluga, …
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(3):253-263
PDF

Invasive candidiasis is a third or fourth cause of sepsis in intensive care units (ICUs). Clinical and pharmacoeconomic study of …
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(3):264-274
PDF